review of glp-1 IUPHAR – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target Shared earlier this week: GLP-1

There are about 7,000 naturally occurring peptide reactions in our bodies daily

There is some evidence that T4 can support wound healing via promoting angiogenesis

This occurs through an in-frame fusion of the EWS gene at 22q12 and the FLI1 gene at 11q24 resulting in the formation of the EWS-FLI1 fusion gene product ( EWS/FLI-1 fusion gene are characterized by small round cells that are arranged closely to form a Homer-Wright daisy-chain structure and the membrane-positive staining for the MIC gene product, CD99, in 90% of the cases

Access to GLP-1 therapy has become more convenient, especially with telehealth services

Disulfide bond scrambling While tirzepatide does not contain traditional disulfide bonds, it does contain a C20 fatty diacid chain attached via a linker to a lysine residue